HNRNPH1
protein-codingheterogeneous nuclear ribonucleoprotein H1, the group of RNA binding motif containing|Heterogeneous nuclear ribonucleoproteins
Gene summary
This gene encodes a member of a subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins that complex with heterogeneous nuclear RNA. These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some may shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has three repeats of quasi-RRM domains that bind to RNA and is very similar to the family member HNRPF. This gene may be associated with hereditary lymphedema type I. Alternatively spliced transcript variants have been described [provided by RefSeq, Mar 2012]
- HNRPH1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0859301
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: ClinGen
*HNRNPH1* was first reported in relation to autosomal dominant syndromic intellectual disability in 2018 (Pilch et al., PMID: 29938792). The authors reported a male proband with a *de novo* p.Arg206Trp variant, which is analogous to the recurrent *HNRNPH2* variant associated with HNRNPH2-related X-linked intellectual disability, Bain type. Affected individuals present with syndromic intellectual disability, dysmorphic facial features, absent or minimal verbal skills, brain abnormalities, ophthalmological abnormalities, genitourinary malformations, short stature, microcephaly, and hypotonia. Eight *de novo* variants (4 missense, 1 in-frame deletion, 2 frameshift, and 1 splice) reported in ten probands in five publications (PMIDs: 23934111, 29938792, 32335897, 32685970, 33874999) are included in this curation. Four probands had missense variants affecting the Arg206 mutational hotspot within the nuclear localization signal, including three with p.Arg206Trp. Additional cases with *HNRNPH1* *de novo* variants have been reported, but they were not included in this curation because individual phenotype information was not provided (PMIDs: 33057194, 33077954). Pathogenic *HNRNPH1* missense variants, particularly in the nuclear localization signal, may disrupt nuclear import and nucleic acid binding, leading to cytoplasmic accumulation and a possible toxic gain- or complex loss-of-function mechanism (PMIDs: 20308327, 40591994). Loss-of-function variants likely act through haploinsufficiency (PMIDs: 23934111, 32335897). This gene-disease relationship is also supported by the biochemical function of HNRNPH1 and protein interaction. HNRNPH1 belongs to the heterogeneous nuclear ribonucleoprotein (HNRNP) gene family, which regulates mRNA processing mechanisms, including RNA splicing; several genes in this family (*HNRNPC*, *HNRNPD*, *HNRNPH2*, *HNRNPK*, *SYNCRIP* [also known as *HNRNPQ*], *HNRNPR*, and *HNRNPU*) have been implicated in syndromic intellectual disability (PMID: 33874999). In summary, there is definitive evidence supporting the relationship between *HNRNPH1* and autosomal dominant syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on October 16, 2024 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0859301
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HNRNPH1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001257293.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 2 | 11 | |||
| missense | 3 | 1 | 64 | 68 | ||
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 3 | 4 | 9 | ||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 5 | 5 | 74 | 9 | 2 | 95 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001244222.1 | 12 | MANE Select | |
| Ensembl | ENSP00000377082.4 | 12 | MANE Select | |
| RefSeq | NP_001350501.1 | 11 | Standard | |
| RefSeq | NP_001351154.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- MECP2 and Associated Rett Syndrome
- mRNA Processing
- FGFR2 alternative splicing
- Signaling by FGFR2
- Signal Transduction
Biological Process
- mRNA splicing, via spliceosome
- RNA processing
- fibroblast growth factor receptor signaling pathway
- RNA metabolic process
- regulation of RNA splicing
Molecular Function
- RNA binding
- protein binding
- poly(U) RNA binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
- membrane
- catalytic step 2 spliceosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356731
- Coding exons
- 12
- Length
- 20607
- Individuals with no LoFs
- 125732
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125734
- p
- 0.00000795
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.09 | 74 | 259 | 0.285 | 0.0000134 | 2963 |
| Missense (PolyPhen) | 14 | 64.594 | 0.21674 | 814 | ||
| Synonymous | -0.0754 | 90 | 89.1 | 1.01 | 0.00000495 | 826 |
| Loss of Function | 4.84 | 0 | 27.3 | 0.00 | 0.00000143 | 326 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation. Inhibits, together with CUGBP1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds poly(RG). {ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:16946708}.;
Intolerance Scores
- LoFtool
- 0.0638
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 33.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.958
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |